Liver cancer risk check for people with type 2 diabetes
Part of Cancer, Digestive system, Hormones & metabolism clinical trials.
This study checks if a simple score (FIB-4) can help find early liver cancer in people with type 2 diabetes. It aims to see if regular monitoring could help catch cancer sooner.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have type 2 diabetes and visit your doctor regularly.
- Your FIB-4 score (based on recent blood tests) is above 2.67.
- You do not have hepatitis B or active hepatitis C.
- You are not pregnant and not planning to become pregnant if you are female.
- You have not had liver cancer before and do not have liver cirrhosis.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is testing a new way to predict if people with chronic hepatitis B, who also have liver fibrosis or cirrhosis, might develop liver cancer (HCC). It uses your medical data to create a risk score, which could help you and your doctor plan earlier and more tailored monitoring.
This study tests whether offering an ultrasound and a blood test (alpha-fetoprotein) every 6 months can help find liver cancer early in people with cirrhosis (scarred liver) caused by conditions other than hepatitis B or C. The goal is to reduce deaths from liver cancer in this group.
This study looks at how well a simple blood test (called FIB-4) can measure liver damage (fibrosis) in people with type 2 diabetes. You may join to help find out if this test can help detect liver problems early.
This study tests a new way to screen for liver cancer in people with chronic liver disease, especially those with cirrhosis or significant liver scarring. It uses blood tests and imaging to catch cancer early.
This study looks at your risk of developing liver cancer if you have hepatitis B. It uses your medical history and test results to give you a better idea of your risk and help guide next steps.
This study looks at whether adding a blood test (the GAAD score) to standard imaging can better detect liver cancer at an early stage in people with chronic liver disease. It may help you if you have cirrhosis or certain types of liver scarring.
Hear when a new Type 2 Diabetes (T2DM) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.